课题基金 / 基金详情

gp130 cytokines and IL-33 in progression to chronic lung fibrosis

gp130 cytokines and IL-33 in progression to chronic lung fibrosis
gp130 细胞因子和 IL-33 进展为慢性肺纤维化
批准号:
357279
负责人:
Richards Carl D
金额:
$40.96万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-10-01 至 2020-10-01

项目摘要

项目成果

Richards Carl D的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Buildup of scar tissue in chronic lung diseases such as idiopathic pulmonary fibrosis (IPF) results in local events in lungs that compromise lung function. These include the accumulation of inflammatory cells and decreases in oxygen exchange, and IPF pat
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of Mucosal Barrier Dysfunction in Severe Lung Inflammation
  • 批准号:
    468914
  • 项目类别:
    Operating Grants
  • 资助金额:
    $57.68万
  • 财政年份:
    2022
  • 负责人:
    Richards Carl D
  • 依托单位:
Regulation of stromal cell support of cancer in lungs
  • 批准号:
    307005
  • 项目类别:
    Operating Grants
  • 资助金额:
    $24.36万
  • 财政年份:
    2014
  • 负责人:
    Richards Carl D
  • 依托单位:
Mediation of allergic airway inflammation and pathology by Oncostatin M
  • 批准号:
    189300
  • 项目类别:
    Operating Grants
  • 资助金额:
    $55.06万
  • 财政年份:
    2009
  • 负责人:
    Richards Carl D
  • 依托单位: